PRESCRIPTION PATTERN OF GLUCOSE-LOWERING AGENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DYSLIPIDAEMIA: A CROSS-SECTIONAL STUDY

Background:- Type 2 diabetes mellitus (T2DM) frequently coexists with dyslipidaemia and significantly increases the risk of cardiovascular disease. Rational prescribing of glucose-lowering and lipid-lowering medications is essential to achieve optimal metabolic control and reduce long-term complications. Evaluating prescribing trends using World Health Organization (WHO) prescribing indicators provides insight into the rationality of pharmacotherapy in clinical practice. Methods:-A cross-sectional observational study was conducted in the General Medicine outpatient department of MGM Hospital, Chhatrapati Sambhaji Nagar, India, between January and June 2025. Six hundred consecutive prescriptions of patients diagnosed with T2DM and dyslipidaemia were analysed. Data regarding demographic characteristics, and WHO core prescribing indicators were collected. Descriptive statistics were used to summarize prescribing patterns.